Staying up-to-date on the latest myeloma research and treatments can help patients feel well-informed and confident when discussing therapy and making decisions with their healthcare team. Innovative Myeloma Therapies is meant to educate and empower patients and care partners to learn more about novel myeloma care options. The program includes:
Expert Interviews on Myeloma Treatment
This program is supported by a charitable contribution from Janssen Pharmaceutical Companies of Johnson & Johnson.